SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-16-114677
Filing Date
2016-04-27
Accepted
2016-04-27 16:08:14
Documents
4
Effectiveness Date
2016-04-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A a16-8992_3defa14a.htm DEFA14A 32179
2 GRAPHIC g89923bci001.gif GRAPHIC 53726
3 GRAPHIC g89923bci002.gif GRAPHIC 71227
4 GRAPHIC g89923bci003.gif GRAPHIC 24440
  Complete submission text file 0001104659-16-114677.txt   239259
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744 512-681-5252
Mirna Therapeutics, Inc. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37566 | Film No.: 161595415
SIC: 2834 Pharmaceutical Preparations